Angiosarcoma of the Breast: Case Report

Angiosarcoma is a rare and aggressive tumor of the breast arising from endothelial cells. It is usually associated with chronic lymphedema or radiation therapy. The diagnosis is made by biopsy and there is no specific finding on mammography. In this study, we report a 59-year-old woman with a history of radiotherapy for invasive ductal carcinoma who subsequently developed primary angiosarcoma of the breast. Angiosarcoma of the breast was first documented in 1887 and is classified as primary and secondary. While surgical R0 resection is recommended for the treatment of these tumors with unclear etiology, the significance of axillary lymph node dissection remains uncertain. Adjuvant radiotherapy has been shown to reduce the local recurrence rate, but adjuvant chemotherapy and radiotherapy have no significant effect on 5-year survival. Although there is no consensus on treatment regimens, it is concluded that more comprehensive studies should be conducted in a larger sample.

Authors

Institutions

Publication Details

Journal
OSMANGAZİ JOURNAL OF MEDICINE
Published
2024-11-12
DOI
https://doi.org/10.20515/otd.1516838
Primary Topic
Vascular Tumors and Angiosarcomas
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Angiosarcoma of the Breast: Case Report

Arda Şakir Yılmaz, Bartu Badak, Nazlı Sena Şeker, Mithat Mert Yurdakul et al.
OSMANGAZİ JOURNAL OF MEDICINE
Vascular Tumors and Angiosarcomas
article

Angiosarcoma of the Breast: Case Report

Arda Şakir Yılmaz, Bartu Badak, Nazlı Sena Şeker, Mithat Mert Yurdakul, Furkan Albayrak
article en

Abstract

Angiosarcoma is a rare and aggressive tumor of the breast arising from endothelial cells. It is usually associated with chronic lymphedema or radiation therapy. The diagnosis is made by biopsy and there is no specific finding on mammography. In this study, we report a 59-year-old woman with a history of radiotherapy for invasive ductal carcinoma who subsequently developed primary angiosarcoma of the breast. Angiosarcoma of the breast was first documented in 1887 and is classified as primary and secondary. While surgical R0 resection is recommended for the treatment of these tumors with unclear etiology, the significance of axillary lymph node dissection remains uncertain. Adjuvant radiotherapy has been shown to reduce the local recurrence rate, but adjuvant chemotherapy and radiotherapy have no significant effect on 5-year survival. Although there is no consensus on treatment regimens, it is concluded that more comprehensive studies should be conducted in a larger sample.

OSMANGAZİ JOURNAL OF MEDICINEVol. 47(1)
Eskişehir Osmangazi Üniversitesi Tıp Fakültesi Hastanesi (TR), Eskişehir City Hospital (TR), Yunus Emre Hastanesi (TR)
Good health and well-being
Openalex Percentile: Top 64%
Vascular Tumors and Angiosarcomas
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.